Poland· PL-100184652
Evoltra
A clofarabine product containing clofarabinum, registered in Poland by Sanofi B.V.. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Clofarabine is registered in 15 of 19 countries.
Countries holding a registration under ATC L01BB06 (clofarabine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Clofarabine · ATC L01BB06
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Clofarabinum
- Manufacturer
- Sanofi B.V.
- Country
- Poland (PL)
- ATC code
- L01BB06
- ATC class
- Clofarabine
- Defined daily dose
- 8.8 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
- gtin05909990634996
- gtin05909990635009
- gtin05909990635016
- gtin05909990635023
- gtin05909990710997
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
530 interactions on record for clofarabine.
Graded by severity as the source publishes them — 41 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clofarabine · interactions on record
530 records
- 41 severe
- 445 moderate
- 12 minor
- 32 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- CidofovirJ05AB12severe
- ClotrimazoleA01AB18moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Clofarabine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEVOLTRASanofi B.V., Amsterdam
- FinlandClofarabine AvansorAvansor Pharma Oy
- BelgiumEvoltra 1 mg/mlSanofi
- SwedenClofarabine Avansor 1 mg/ml Koncentrat till infusionsvätska, lösningAvansor Pharma Oy
- NorwayEvoltraSanofi B.V.
- IcelandEvoltraGenzyme Europe B.V.
- IrelandEvoltra 1 mg/ml concentrate for solution for infusionSanofi B.V.
- United StatesClofarabineGland Pharma Limited
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Clofarabin Koanaa
- Bulgaria · Клофарабин Зентива
- Germany · Clofarabin Ratiopharm
- Spain · Clofarabin Teva, Clofarabina Accord
- France · Clofarabine Accord, Clofarabine Tillomed
- United Kingdom (Northern Ireland) · Clofarabine Sandoz
- Greece · Ebroka
- Iceland · Evoltra
- Italy · Clofarabina Medac
- Liechtenstein · Evoltra
- Netherlands · Clofarabine Accord, Clofarabine Genthon
- Norway · Evoltra
- Portugal · Clofarabina Accord, Clofarabina Vivanta
- Romania · Clofarabină Vivanta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b65ec2d2-412d-4d83-9dae-eea8e219f50d GET /v1/drugs/b65ec2d2-412d-4d83-9dae-eea8e219f50d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "1 mg/ml",
"packaging": "05909990634996 ¦ Rpz ¦ EU/1/06/334/001 ¦ 34902\n3 fiol. 20 ml\n05909990635009 ¦ Rpz ¦ EU/1/06/334/002 ¦ 41997\n4 fiol. 20 ml\n05909990635016 ¦ Rpz ¦ EU/1/06/334/003 ¦ 42066\n10 fiol. 20 ml\n05909990635023 ¦ Rpz ¦ EU/1/06/334/004 ¦ 42093\n20 fiol. 20 ml\n05909990710997 ¦ Rpz ¦ EU/1/06/334/005 ¦ 51361\n1 fiol. 20 ml",
"substance": "Clofarabinum 1 mg/ml",
"common_name": "Clofarabinum",
"pl_product_id": "100184652",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about clofarabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.